Paper Details

  1. Home
  2. Paper Details

Systematic review of medical treatment in melanoma: current status and future prospects.

Author: EigentlerThomas K, GarbeClaus, HauschildAxel, KeilholzUlrich, KirkwoodJohn M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Melanoma is a growing problem worldwide. While treatment for early melanoma involves surgery and additional therapies, the outlook for advanced or metastatic melanoma remains poor. Standard chemotherapy for advanced melanoma has low response rates, and treatments like cytokine therapy have significant side effects. This review examines current treatments for advanced melanoma and discusses promising new therapies under development that may improve outcomes.
Paper Details　
Original Abstract of the Article :
The incidence of melanoma is increasing worldwide, and the prognosis for patients with high-risk or advanced metastatic melanoma remains poor despite advances in the field. Standard treatment for patients with thick (≥2.0 mm) primary melanoma with or without regional metastases to lymph nodes is sur...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228046/

データ提供：米国国立医学図書館（NLM）

Navigating the Shifting Sands of Melanoma Treatment

The fight against melanoma, a formidable foe in the realm of cancer, is constantly evolving. This systematic review provides a comprehensive overview of current melanoma treatment strategies and explores promising avenues for future research. The authors delve into the complexities of melanoma treatment, highlighting the challenges faced in treating high-risk and advanced metastatic disease. While surgery followed by adjuvant therapy remains the standard of care for early-stage melanoma, the prognosis for advanced disease remains bleak. The review outlines the limitations of traditional chemotherapy and the potential of newer therapies, such as cytokine therapy with IL-2, which shows promise in achieving durable benefits despite its associated toxicities.

Charting a New Course in Melanoma Treatment

This study provides a crucial update on melanoma treatment, outlining the successes and limitations of current approaches. The authors highlight the need for novel therapies that can overcome the limitations of existing treatment options and improve the outcomes for patients with advanced melanoma. The study emphasizes the importance of ongoing research and clinical trials to advance our understanding of melanoma and develop more effective treatment strategies.

Hope on the Horizon: A New Era of Melanoma Treatment

The research underscores the importance of continuous innovation in the fight against melanoma. The authors emphasize the need for collaborative efforts to develop novel therapies, improve diagnostic tools, and optimize treatment strategies. By joining forces, we can navigate the shifting sands of melanoma treatment and bring hope to patients facing this challenging disease.

Dr. Camel's Conclusion

This review provides a timely and insightful overview of the current landscape of melanoma treatment. The authors have expertly summarized the challenges and opportunities in this field, highlighting the need for continued research and innovation. The quest to conquer melanoma is a marathon, not a sprint, and this review provides a crucial roadmap for our journey.

Date :
  1. Date Completed 2011-06-28
  2. Date Revised 2022-04-19
Further Info :

Pubmed ID

21212434

DOI: Digital Object Identifier

PMC3228046

Related Literature

Article Analysis
・Effective treatment of melanoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.